1. Multimodality Treatment of Pulmonary Sarcomatoid Carcinoma: A Review of Current State of Art
    Lin Zhang et al, 2022, Journal of Oncology CrossRef
  2. Advances in Diagnosis and Treatment of Pulmonary Sarcomatoid Carcinoma
    亚男 梁, 2023, Advances in Clinical Medicine CrossRef
  3. Recent advances in the management of pulmonary sarcomatoid carcinoma
    Elaine Shum et al, 2016, Expert Review of Respiratory Medicine CrossRef
  4. Definitive Chemoradiotherapy for Advanced Pulmonary Sarcomatoid Carcinoma
    Kazuya Takeda et al, 2016, Internal Medicine CrossRef
  5. Pulmonary sarcomatoid carcinoma: progress, treatment and expectations
    Xin Li et al, 2020, Therapeutic Advances in Medical Oncology CrossRef
  6. Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma
    Chia-Ling Chang et al, 2022, Therapeutic Advances in Medical Oncology CrossRef
  7. Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid Carcinoma
    Jiachun Sun et al, 2022, Frontiers in Oncology CrossRef
  8. Partial response to pralsetinib in an advanced pulmonary sarcomatoid carcinoma patient harboring a KIF5B-RET rearrangement: a case report
    Ying Wu et al, 2022, World Journal of Surgical Oncology CrossRef
  9. KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma
    Mitra Mehrad et al, 2018, Histopathology CrossRef
  10. Epidemiological features of lung giant cell carcinoma and therapy for patients with EGFR mutations based on case reports and the surveillance, epidemiology, and end results (SEER) database
    Shan-Shan Weng et al, 2017, Oncotarget CrossRef
  11. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling
    Alexa B. Schrock et al, 2017, Journal of Thoracic Oncology CrossRef
  12. Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma
    Jae Kyeom Sim et al, 2018, The Korean Journal of Internal Medicine CrossRef
  13. DNA Repair Genes ERCC1 and BRCA1 Expression in Non-Small Cell Lung Cancer Chemotherapy Drug Resistance
    Shuai Wang et al, 2016, Medical Science Monitor CrossRef
  14. Response to gefitinib/crizotinib combination in a pulmonary sarcomatoid carcinoma patient harboring concurrent EGFR mutation and MET amplification
    Xiaomeng Wang et al, 2021, Clinical Case Reports CrossRef
  15. Clinicopathological features and prognostic nomogram of giant cell carcinoma of the lung: A population‐based study
    Jiang He et al, 2023, The Clinical Respiratory Journal CrossRef
  16. Targeted therapy for rare lung cancers: Status, challenges, and prospects
    Chunsen Wang et al, 2023, Molecular Therapy CrossRef
  17. The treatment of advanced pulmonary sarcomatoid carcinoma
    Yue Zheng et al, 2022, Future Oncology CrossRef